Transcription of Annex 2 Recommendations for inactivated rabies …
{{id}} {{{paragraph}}}
83 World Health OrganizationWHO Technical Report Series No 941, 2007 Annex 2 Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggsThese Recommendations provide information and guidance to national regulatory authorities and vaccine manufacturers concerning the characterization, production and control of rabies vaccines in order to facilitate their international licensure and use. Each of the following sections constitutes a recommendation. The parts of each section that are printed in normal type have been written in the form of requirements so that if a national regulatory authority so desires these parts may be adopted as defi nitive national requirements. The parts of each section printed in small type are comments and additional guidance.
84 Introduction The last revision of the requirements for rabies vaccines for human use was in 1980 (1).However, an additional document, WHO Requirements
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}